Lifeline Scientific, Inc. is a developer of products and services for cell, tissue and organ transplantation. The Company is engaged in the business of delivering a portfolio of related technologies, which include devices, solutions and protocols designed to maximize the use and availability of organs, tissues and cells. Its business units include Organ Recovery Systems and Tissue Testing Technologies (T3). Organ Recovery Systems is the transplant community's provider of products and services for donor organ recovery, preservation and transport. T3 is a cryobiology research laboratory focused on developing approaches to preserve, transport, and evaluate biological living materials for transplantation, and other clinical and research applications. Its products include LifePort Kidney Transporter, LifePort Liver Transporter, Vasosol, Universal SealRing Cannula and LifePort WorkStation. It also offers SPS-1, a Static Preservation Solution and KPS-1, a Kidney Perfusion Solution.
Industry, Sector and Symbol:
- Sector: Healthcare
- Industry: Advanced Medical Equipment & Technology - NEC
- Sub-Industry: N/A
- Symbol: LON:LSIC
- CUSIP: N/A
- Web: www.lifeline-scientific.com/
- 52 Week Range: GBX 175 - GBX 320
- Trailing P/E Ratio:
- P/E Growth:
- Net Margins: 10.65%
- Return on Equity: 10.61%
- Return on Assets: 9.10%
- Average Volume: 4,679 shs.
Frequently Asked Questions for Lifeline Scientific (LON:LSIC)
What is Lifeline Scientific's stock symbol?
Lifeline Scientific trades on the London Stock Exchange (LON) under the ticker symbol "LSIC."
Who are some of Lifeline Scientific's key competitors?
Some companies that are related to Lifeline Scientific include Thermo Fisher Scientific (TMO), Danaher Corporation (DHR), Boston Scientific Corporation (BSX), Intuitive Surgical (ISRG), Koninklijke Philips N.V. (PHG), Illumina (ILMN), Edwards Lifesciences Corporation (EW), Cerner Corporation (CERN), Agilent Technologies (A), Waters Corporation (WAT), Hologic (HOLX), ResMed (RMD), Varian Medical Systems (VAR), PerkinElmer (PKI), ABIOMED (ABMD), Bruker Corporation (BRKR), Alere (ALR) and Accelerate Diagnostics (AXDX).
How do I buy Lifeline Scientific stock?
Shares of Lifeline Scientific and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
What is Lifeline Scientific's stock price today?
MarketBeat Community Rating for Lifeline Scientific (LON LSIC)MarketBeat's community ratings are surveys of what our community members think about Lifeline Scientific and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
One share of Lifeline Scientific stock can currently be purchased for approximately GBX 308.50.
Consensus Ratings for Lifeline Scientific (LON:LSIC) (How are Consensus Ratings Calculated?)
MarketBeat calculates consensus ratings using the most recent rating from each brokerage that has rated a stock within the last twelve months. Since brokers often use different ratings systems, each rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings. Each stock's consensus rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months.
MarketBeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and MarketBeat has received a report that coverage was dropped. Ratings from certain research firms that issue ratings using purely quantitative methods (such as Zacks, Vetr and ValuEngine) are not included in consensus calculations. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
|Ratings Breakdown: ||No ratings tracked in the last 12 months.|
|Consensus Rating:||N/A (Score: NaN)|
|Consensus Price Target: ||N/A|
Analysts' Ratings History for Lifeline Scientific (LON:LSIC)
No equities research coverage for this company has been tracked by MarketBeat.com
Earnings History for Lifeline Scientific (LON:LSIC)
No earnings announcements for this company have been tracked by MarketBeat.com
Earnings Estimates for Lifeline Scientific (LON:LSIC)
Current Year EPS Consensus Estimate: $0.22 EPS
Dividend History for Lifeline Scientific (LON:LSIC)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading History for Lifeline Scientific (LON:LSIC)
No insider trades for this company have been tracked by MarketBeat.com
Headline Trends for Lifeline Scientific (LON:LSIC)
Latest Headlines for Lifeline Scientific (LON:LSIC)
Lifeline Scientific (LSIC) Chart for Wednesday, July, 26, 2017